M&T Bank
CGON icon

M&T Bank’s CG Oncology CGON Stock Holding History

M&T Bank’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267K Sell
3,750
-336
-8% -$22K ﹤0.01% 1519
2026
Q1 		$277K Buy
+4,086
New +$232K ﹤0.01% 1417
2025
Q1 		– Sell
-16,891
Closed -$485K – 1575
2024
Q4 		$485K Buy
16,891
+133
+0.8% +$4.55K ﹤0.01% 1179
2024
Q3 		$632K Buy
16,758
+5,996
+56% +$210K ﹤0.01% 1072
2024
Q2 		$340K Buy
10,762
+1,182
+12% +$41K ﹤0.01% 1263
2024
Q1 		$420K Buy
+9,580
New +$391K ﹤0.01% 1200

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

M&T Bank's CGON Position: Q2 2026 in Review

M&T Bank reduced its CG Oncology (CGON) stake by 8.2% in Q2 2026, selling an estimated $22K and leaving 3,750 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #1519.

M&T Bank first reported a position in CGON in Q1 2024 and has held it in 6 quarters since. The position peaked at $632K in Q3 2024. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • M&T Bank held 3,750 shares of CG Oncology worth $267K as of Q2 2026.
  • M&T Bank sold 336 CG Oncology shares in Q2 2026, an estimated $22K.
  • CG Oncology made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1519 holding.
  • M&T Bank first reported a position in CG Oncology in Q1 2024 and has held it in 6 quarters since.
  • M&T Bank's CG Oncology position peaked at $632K in Q3 2024.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.